Viewing StudyNCT06439693



Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06439693
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2024-05-28

Brief Title: The SAPPHO Study A Single-Arm Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2 Metastatic Breast Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Stage IV Breast Cancer
Breast Cancer Female
Breast Cancer
Breast Cancer Metastatic
Estrogen Receptor-positive Breast Cancer
HER2-positive Breast Cancer
Keywords:
Name View
Stage IV Breast Cancer View
Breast Cancer View
Breast Cancer Female View
Breast Cancer Metastatic View
Estrogen Receptor-Positive Breast Cancer View
HER2-positive Breast Cancer View